BOSTON, MA -- (Marketwired) -- 11/08/17 -- Real world evidence is poised to play a growing…
Continue ReadingTag: pharmaceutical
Cardiovascular Drug Approval Rate in the U.S. Fell as Development Time Rose, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 09/12/17 -- Although the rate at which investigational drugs received marketing…
Continue ReadingAbuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 07/13/17 -- Although 10 new opioid products with abuse-deterrent formulations (ADF)…
Continue ReadingAccelerating Pace of Approvals and a Strong Development Pipeline Indicate Vigorous Growth for New Biotech Products, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 05/09/17 -- Biopharmaceuticals accounted for 35% of all new drug approvals…
Continue ReadingPoor Physician and Nurse Engagement Contributes to Low Patient Recruitment Rates, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 01/11/17 -- Although physicians and nurses are familiar with, and comfortable…
Continue ReadingSynergy CHC Corp creates deeper Partnership with Knight Therapeutics
WESTBROOK, ME — (Marketwired) — 01/04/17 — Synergy CHC Corp (“Synergy”) (OTCQB: SNYR) and Knight Therapeutics…
Continue ReadingCost to Develop and Win Marketing Approval for a New Drug Is $2.6 Billion, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 11/18/14 -- Developing a new prescription medicine that gains marketing approval,…
Continue ReadingADVISORY – Tufts CSDD to Disclose Cost of Developing a New Drug at Nov. 18 Briefing
BOSTON, MA -- (Marketwired) -- 11/10/14 --Tufts Center for the Study of Drug Development, Tufts University,…
Continue ReadingTherapeutic Area Partnerships Features Next Generation of Oncology Treatments
New Wave of Newer Classes Will Be Discussed by Experts at Campbell Alliance
Continue ReadingTherapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed
BRIDGEWATER, NJ -- (Marketwire) -- 10/29/12 -- Elsevier Business Intelligence hosts the 7th Annual Therapeutic Area…
Continue Reading